Hiroaki Yamagami 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（13 件）

• [2024] Elderly patient with unresectable advanced‑stage hepatocellular carcinoma who received atezolizumab plus bevacizumab and achieved a complete response: A case report
  DOI: https://doi.org/10.3892/mi.2024.147
• [2024] Outcomes of 707 cervical selective nerve root blocks using a fluoroscopy–guided posterolateral oblique approach
  DOI: https://doi.org/10.11154/pain.39.26
• [2023] Hepatitis E Virus Infection Caused Elevation of Alanine Aminotransferase Levels in a Patient with Chronic Hepatitis B and Choledocholithiasis
  DOI: https://doi.org/10.3390/reports6040055
• [2023] Muscle Cramps in Outpatients with Liver Diseases in Tokyo, Japan
  DOI: https://doi.org/10.3390/medicina59091506
• [2022] A Case of Recent Liver Injury Induced by Benzbromarone
  DOI: https://doi.org/10.3390/reports5010008
• [2022] COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report
  DOI: https://doi.org/10.21873/invivo.12923
• [2021] HCV GT1b-patient With Alanine Aminotransferase Elevation and Sustained Virologic Response Achieved By grazoprevir/elbasvir Discontinuation
  DOI: https://doi.org/10.2217/fvl-2020-0181
• [2021] Male-Dominant Hepatitis A Outbreak Observed among Non-HIV-Infected Persons in the Northern Part of Tokyo, Japan
  DOI: https://doi.org/10.3390/v13020207
• [2021] Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series
  DOI: https://doi.org/10.21873/anticanres.15442
• [2021] Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan
  DOI: https://doi.org/10.3390/jcm10235529

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。